59th Annual Meeting of the Japanese Society of Neurology

Presentation information

Print

Luncheon Seminar

[LS-23] Takeda Pharmaceutical Company Limited.

MOA-B inhibitor, Rasagiline as a novel agent for treatment of Parkinson's disease

Fri. May 25, 2018 11:30 AM - 12:30 PM Room 2 (Sapporo Geibunkan / Zuisetsu （3F）)

Chair: Ryosuke Takahashi(Department of Neurology, Graduate School of Medicine, Kyoto University)

[LS-23-1] The role of MOA-B inhibitor, Rasagiline for the treatment of early stage Pakinson’s disease

○Nobutaka Hattori (Department of Neurology, Juntendo University School of Medicine)